D. Lindner

发表

Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: Eight-day randomized clinical trial in Korea.

I. Jang, A. Tricker, R. Dempsey, 2012, Regulatory toxicology and pharmacology : RTP.

Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management

V. Backer, A. Meiners, S. Lane, 2018, Therapeutic advances in respiratory disease.

Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study

P. Malfertheiner, S. Willich, M. Vieth, 2003, Alimentary pharmacology & therapeutics.

Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study

Deng-Chyang Wu, Suk-Kyun Yang, R. Banerjee, 2020, Intestinal research.

Vedolizumab treatment persistence and safety in a 2‐year data analysis of an extended access programme

S. Vermeire, K. Subramaniam, S. Danese, 2020, Alimentary pharmacology & therapeutics.

Early Intervention With Vedolizumab and Longer-term Surgery Rates in Crohn’s Disease: Post Hoc Analysis of the GEMINI Phase 3 and Long-term Safety Programmes

L. Peyrin-Biroulet, P. Dulai, V. Jairath, 2020, Journal of Crohn's & colitis.

Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn’s Disease or Ulcerative Colitis

S. Vermeire, S. Danese, M. Lukáš, 2020, Journal of Crohn's & colitis.

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

Deng-Chyang Wu, U. Jalihal, C. Ooi, 2020, Intestinal research.

Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study

S. Vermeire, W. Sandborn, I. Dotan, 2022, Alimentary pharmacology & therapeutics.

Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: Eight-day randomized clinical trial in the UK.

C. Leroy, A. Tricker, R. Dempsey, 2012, Regulatory toxicology and pharmacology : RTP.

Efficacy and tolerability of two home bleaching systems having different peroxide delivery

T. Attin, C. Hannig, D. Lindner, 2007, Clinical Oral Investigations.

Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis

K. Hoffmann, J. Jentzsch, Cindy Richter, 2022, Frontiers in Neurology.

Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-Day randomized clinical trial in Japan.

C. Leroy, A. Tricker, S. Kanada, 2012, Regulatory toxicology and pharmacology : RTP.

Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland.

J. Magnette, Agnieszka Kulesza, K. Jarus-Dziedzic, 2012, Regulatory toxicology and pharmacology : RTP.

Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-Day randomized clinical trial of a menthol cigarette in Japan.

A. Tricker, S. Kanada, R. Dempsey, 2012, Regulatory toxicology and pharmacology : RTP.

Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay

G. Smithson, N. Vande Casteele, A. Suri, 2023, Therapeutic drug monitoring.

Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

J. Panés, D. García-Olmo, A. Spinelli, 2021, Diseases of the colon and rectum.

S0652 Real World Exposure-Response Relationship of Vedolizumab in Inflammatory Bowel Disease: A Pooled Multicenter Observational Cohort Analysis of Clinical and Modeled Pharmacological Data

S. Vermeire, W. Sandborn, I. Dotan, 2020 .

OP04 Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trial

M. Silverberg, P. Gionchetti, S. Danese, 2022, Journal of Crohn's and Colitis.

P537 The impact of early disease control with vedolizumab on surgery rates among patients with Crohn’s disease: a post-hoc analysis of the GEMINI trials

L. Peyrin-Biroulet, P. Dulai, H. Patel, 2019, Journal of Crohn's & Colitis.

Comparison of Exposure to Selected Cigarette Smoke Constituents in Adult Smokers and Nonsmokers in a European, Multicenter, Observational Study

C. Leroy, A. Tricker, D. Lindner, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Fluid Balance Variations During the Early Phase of Large Hemispheric Stroke Are Associated With Patients' Functional Outcome

M. Fischer, C. Fricke, D. Michalski, 2019, Front. Neurol..

Vedolizumab for the Treatment of Chronic Pouchitis.

M. Silverberg, S. Travis, M. Ferrante, 2023, The New England journal of medicine.